与LABA或LAMA处方的COPD患者之间的心血管结果:一个现实世界的领土广泛研究
Chun Ka Wong1, Eugene C C Cheng1, Ali Choo1
1Faculty of Medicine, Cardiology Division, Department of Medicine, School of Clinical Medicine, Li Ka Shing, The University of Hong Kong, Hong Kong SAR, China.
Advances in therapy
|October 18, 2025
概括
与长效β-agonist (LABA) 疗法相比,长效肌抗剂 (LAMA) 治疗COPD可能会增加心血管事件的风险,特别是心房动. 需要进一步的研究来证实这些发现在COPD药物治疗选择中.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 药物治疗 药物治疗
背景情况:
- 慢性阻塞性肺病 (COPD) 管理涉及药物治疗选择,具有潜在的心血管影响.
- 长效β-激动剂 (LABA) 和长效肌抗体 (LAMA) 是慢性肺炎的常见支气管扩展剂.
- 了解心血管安全的比较对于优化COPD治疗至关重要.
研究的目的:
- 为了比较用LABA治疗的COPD患者与LAMA治疗的患者之间的心血管结果.
- 为在COPD患者中选择支气管扩展剂治疗的临床决策提供信息.
主要方法:
- 使用香港电子患者数据 (2010-2019) 进行了现实世界的回顾性队列研究.
- 开始LABA或LAMA的COPD患者,没有先前的心血管疾病,被跟踪了3年.
- 倾向性得分匹配被用来控制患者的特征和临床特征.
主要成果:
- 在倾向性得分匹配后,分析了5020名患者 (2510 LABA,2510 LAMA).
- 与LABA相比,LAMA治疗与整体心血管事件的发病率较高 (20.2%与19.0%,aHR 1.14,p=0.04).
- 这种差异主要是由于LAMA新发性心房的风险更高 (7.93%对6.53%,aHR1.30,p=0.01).
结论:
- 与LABA相比,COPD患者的LAMA治疗可能与心房的发病率增加有关.
- 在其他心血管事件 (如急性冠状动脉综合征或缺血性中风) 中没有发现显著差异.
- 这些发现表明需要仔细考虑LAMA疗法在COPD患者心血管风险因素.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
692
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
692
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K